TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 125 filers reported holding TREACE MED CONCEPTS INC in Q1 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,351,344 | +457.6% | 179,355 | +988.1% | 0.00% | – |
| Q2 2023 | $421,661 | +21.7% | 16,484 | +19.8% | 0.00% | – |
| Q1 2023 | $346,615 | +21.6% | 13,760 | +11.0% | 0.00% | – |
| Q4 2022 | $285,076 | -6.5% | 12,400 | -10.1% | 0.00% | – |
| Q3 2022 | $305,000 | +77.3% | 13,795 | +14.6% | 0.00% | – |
| Q2 2022 | $172,000 | -21.8% | 12,037 | +3.1% | 0.00% | – |
| Q1 2022 | $220,000 | -1.3% | 11,673 | -2.7% | 0.00% | – |
| Q4 2021 | $223,000 | – | 12,003 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 1,907,823 | $25,011,560 | 2.31% |
| FORMULA GROWTH LTD | 222,269 | $2,913,947 | 0.99% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,193,939 | $15,652,540 | 0.94% |
| EMERALD ADVISERS, LLC | 1,473,281 | $19,314,713 | 0.94% |
| Perceptive Advisors | 1,834,060 | $24,044,527 | 0.80% |
| NEXT CENTURY GROWTH INVESTORS LLC | 512,738 | $6,721,995 | 0.73% |
| OBERWEIS ASSET MANAGEMENT INC/ | 355,600 | $4,661,916 | 0.50% |
| Novo Holdings A/S | 360,000 | $4,719,600 | 0.35% |
| TimesSquare Capital Management, LLC | 1,433,429 | $18,792 | 0.29% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 677,733 | $8,885,080 | 0.18% |